Search the Newsreel

SK Hynix, Samsung Extend Gains After Report Temasek to Invest

(Bloomberg) -- South Korean chipmakers extended gains following a local media report that Singapore's Temasek Holdings Pte plans to invest in their stocks. Most Read from Bloomberg Five Takeaways From Zuckerberg's 6,500-Word Manifesto on AI Pakistan Says Deal Is Close Even as Iran, US …

What Is SK hynix (NasdaqGS:SKHY) Facing With South Korea's Chip Fund And Leak Case?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. SK hynix (NasdaqGS:SKHY) has been named in South Korea's new $3.5b semiconductor fund and …

Algorhythm Holdings to Announce its Financial Results for the Second Quarter of 2026

Algorhythm Holdings, Inc. (NASDAQ: RIME), a leading AI-powered logistics solutions provider, announced it will release its second-quarter financial results for the period ending June 30, 2026, on Friday, August 14, 2026. The company, through its subsidiary SemiCab, focuses on optimizing logistics for major retailers …

Hydrofarm Holdings (HYFM) President reports 740-share tax withholding on RSU vesting

Hydrofarm Holdings (HYFM) President Mark S. Parker reported a tax-related disposition where 740 shares of common stock were withheld at $1.60 per share. This was to satisfy a tax withholding obligation stemming from the vesting of 1,667 stock-settled restricted stock units. Following this transaction, …

Hydrofarm (HYFM) CAO Erica Ackerman logs 138-share tax withholding event

Hydrofarm Holdings Group, Inc.'s CAO, Erica Ackerman, reported a tax withholding event on August 8, 2026, involving 138 shares of common stock. These shares, valued at $1.60 each, were withheld to cover tax obligations from the vesting of 334 stock-settled restricted stock units. After …

Rhythm Pharmaceuticals (RYTM) insider outlines 10b5-1 stock sale plan in Form 144

A Rhythm Pharmaceuticals insider, Pamela Cramer, has filed a Form 144 detailing planned sales of company common stock through a 10b5-1 plan via Morgan Stanley Smith Barney LLC. The filing includes shares from stock option exercises and restricted stock units, alongside a previous sale …

iRhythm edges lower amid Spruce Point short comments

[Doctor and patient in conversation, looking at digital tablet] Solskin * iRhythm (IRTC [https://seekingalpha.com/symbol/IRTC]) ticked lower by 2% amid comments from Spruce Point Research. * iRhythm (IRTC [https://seekingalpha.com/symbol/IRTC]) didn't immediately respond to Seeking Alpha's email request for comment. * Spruce Point first issued a …

Murphy Oil drills Lac Da Trang prospect offshore Vietnam

Murphy Oil has spud the Lac Da Trang North-1X exploration well offshore Vietnam, targeting 40 MMbbl to 80 MMbbl of recoverable resources. This prospect could be developed as a tieback to the company's Lac Da Vang project, which is on track for first oil …

Thyssenkrupp nucera AG & Co. KGaA: SOEC-Neuausrichtung führt zu Anpassung der EBIT-Prognose 2025/26; Aktualisierung der Auftragseingangs- und Umsatz-Erwartung auf Basis bisheriger Geschäftsentwicklung

Thyssenkrupp Nucera (WKN NCA000, ISIN DE000NCA0001) - Nachricht anzeigen - News

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: SOEC-Neuausrichtung führt zu Anpassung der EBIT-Prognose 2025/26; Aktualisierung der Auftragseingangs- und Umsatz-Erwartung auf Basis bisheriger Geschäftsentwicklung - boerse.de

PhysicsWallah Q1 Results: Earnings call scheduled for Aug 14

Algorhythm Holdings to report Q2 results

Algorhythm Holdings is scheduled to release its second-quarter 2026 financial results on August 14, 2026. This news brief was generated by Public Technologies using AI and is based on original content published by Algorhythm Holdings Inc. via GlobeNewswire. The information is for informational purposes …

Algorhythm Holdings sets a date to share June-quarter results

Algorhythm Holdings (NASDAQ:RIME) announced it will release its financial results for the second quarter ended June 30, 2026, on Friday, August 14, 2026. The AI-powered logistics solutions provider shared this information from Fort Lauderdale, Florida. Prior comparable earnings-date events for the company have averaged …

SK Hynix Has Suffered Post-IPO as Memory Flags: A Wall Street Pro Remains Sanguine With 160% Returns Predicted

Quick Read SK Hynix dropped 20% post-IPO from $168 to $135 as a broader AI selloff triggered limit-down trading in South Korea's Nextrade system. Macquarie's Daniel Kim sets a Street-high $355 target on SKHY, implying 162% upside from its near-monopoly position supplying NVDA's AI …

Susquehanna Issues Positive Forecast for Hyatt Hotels (NYSE:H) Stock Price

Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment

Rhythm Pharmaceuticals, Inc. -- MHRA grants authorization for patients 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or impairment -- BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused …

SKHY Reportedly Revives China NAND Plant After 4-Year Pause, Days After $39B Korean Fabs Investment

SK Hynix (SKHY) is reportedly restarting construction at its NAND plant in Dalian, China, after a four-year pause, aiming to add 50,000 wafers per month to its NAND capacity by mid-2027. This move follows a recent announcement of a $39 billion investment in two …

iRhythm Technologies $IRTC Shares Acquired by Quantinno Capital Management LP

Quantinno Capital Management LP significantly increased its stake in iRhythm Technologies (NASDAQ:IRTC) by 1,172.8% in the first quarter, now owning 18,621 shares valued at approximately $2.2 million. The company reported strong financial results, with quarterly revenue up 20.1% year over year to $224.17 million …

The Technical Signals Behind (IRTC) That Institutions Follow

This article provides a technical analysis of Irhythm Technologies Inc. (NASDAQ: IRTC), detailing institutional trading strategies based on AI models. It identifies strong near- and mid-term sentiment but a weak long-term outlook, with key support and resistance levels. The analysis also highlights a significant …

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Rhythm Pharmaceuticals (NASDAQ:RYTM) has received a "Moderate Buy" consensus recommendation from brokerages, with 15 out of 18 analysts rating the stock as a buy. The average 12-month price target is $142.44, exceeding the current share price of $115.48. The company reported strong quarterly revenue …

Intercontinental Hotels Group H1 Earnings Call Highlights

Key Points Interested in Intercontinental Hotels Group? Here are five stocks we like better. Strong first-half financial performance: Global RevPAR rose 4.1%, fee revenue increased 7%, operating profit grew 10%, and adjusted EPS climbed 13% to 274.7 cents. IHG raised its interim dividend 10% …

The 5 Most Interesting Analyst Questions From Murphy Oil’s Q2 Earnings Call

PGHH Share Price Today - Procter & Gamble Hygiene and Health Care Stock Analysis

Should iRhythm’s Stronger Q2 2026 Results and Higher Guidance Amid Class Action Settlement Require Action From iRhythm Holdings (IRTC) Investors?

SK hynix Commits $37B to New Yongin, Cheongju Fabs for AI Memory Growth

SK hynix has approved an investment of approximately $37 billion to construct two new semiconductor fabs in South Korea. This strategic expansion in Yongin and Cheongju aims to bolster its production capacity for DRAM and NAND memory, driven by the increasing demand from AI …

Gold Hydrogen Jumps as Key Well Test Begins

(HY) Movement Within Algorithmic Entry Frameworks

This article provides an algorithmic analysis of Hyster-Yale Materials Handling Inc. (NYSE: HY), highlighting strong near and mid-term positive sentiment and a test of support. It outlines three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. …

RHYTHM PHARMACEUTICALS, INC. SEC Filing (Aug 10, 2026)

This article details an SEC Form 144 filing by RHYTHM PHARMACEUTICALS, INC. (RYTM) on August 10, 2026. The filing indicates a proposed sale of 3,520 common shares with an aggregate market value of $407,017.60, acquired through the exercise of stock options on the same …

Gold Hydrogen to Begin Flow Testing at Ramsay 2 Well

Hyperfine, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:HYPR) 2026-08-10

Why iRhythm (IRTC) Stock Is Trading Up Today

Why iRhythm (IRTC) Stock Is Trading Up Today What Happened? Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 2% in the afternoon session after the company reported strong second-quarter financial results that surpassed expectations and raised its full-year guidance. The cardiac monitoring company …

U.S. Physical Therapy, Inc. (NYSE:USPH) Given Consensus Recommendation of "Moderate Buy" by Brokerages

U.S. Physical Therapy, Inc. (NYSE:USPH) has received a consensus "Moderate Buy" rating from seven brokerages, with an average 12-month price target of $97.50 against its current price of $79.89. The company's latest quarterly results showed an 8.5% year-over-year revenue increase to $214.06 million, though …

HD Hyundai Co., Ltd. (267250.KS) stock price, news, quote and history

iRhythm Technologies (NASDAQ:IRTC) Stock Price Expected to Rise, Truist Financial Analyst Says

Truist Financial has increased its price target for iRhythm Technologies (NASDAQ:IRTC) from $160 to $168, maintaining a "buy" rating and indicating a potential upside of 34.59%. This positive outlook aligns with a "Moderate Buy" consensus rating from MarketBeat analysts, despite some recent target reductions …

RYTM - High-Growth Emerging Commercial Stage Biotech

Rhythm Pharmaceuticals (RYTM) is presented as a high-growth commercial-stage biotech company focused on orphan neuroendocrine disorders, particularly those related to MC4R pathway dysfunction (genetic obesity). The article highlights the company's strong Q2 2026 results for IMCIVREE, with better-than-expected patient uptake and international growth, along …